Opendata, web and dolomites

HEDIMED SIGNED

Human Exposomic Determinants of Immune Mediated Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HEDIMED project word cloud

Explore the words cloud of the HEDIMED project. It provides you a very rough idea of what is the project "HEDIMED" about.

fetal    exposomic    generate    cohorts    countries    imds    data    life    ephor    paid    join    diagnostic    huge    28    immune    diabetes    combined    exploratory    combination    omics    altogether    societal    expanse    culture    athlete    asthma    supplementary    causal    children    organ    determinants    trials    genetic    health    synergy    epidemic    eximious    remedia    academic    exploited    cell    latest    exposomice    bhc    mediated    economic    stakeholders    offers    multidisciplinary    hedimed    diseases    underlying    innovations    start    treatments    medical    allergies    resource    350    therapeutic    tools    women    cross    efforts    disease    birth    2020    childhood    associations    identification    multiplex    interactions    forums    samples    equal    biological    functional    heap    sc1    exposome    edge    celiac    rapid    600    cutting    industrial    datamining    sectional    2018    clinical    forces    imd    burden    toolbox    chronic    economical    play    human    emphasis    longitools    interventions    technologies    constituting    ways    pregnant    followed    driving    models    prospectively    preventive    inclusion   

Project "HEDIMED" data sheet

The following table provides information about the project.

Coordinator
TAMPEREEN KORKEAKOULUSAATIO SR 

Organization address
address: KALEVANTIE 4
city: TAMPERE
postcode: 33100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 11˙992˙338 €
 EC max contribution 11˙992˙338 € (100%)
 Programme 1. H2020-EU.3.1.2. (Preventing disease)
 Code Call H2020-SC1-2019-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2024-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) coordinator 1˙562˙782.00
2    TURUN YLIOPISTO FI (Turku) participant 1˙160˙371.00
3    Teknologian tutkimuskeskus VTT Oy FI (Espoo) participant 954˙253.00
4    UNIVERZITA KARLOVA CZ (PRAHA 1) participant 816˙037.00
5    LUNDS UNIVERSITET SE (LUND) participant 646˙512.00
6    FOLKEHELSEINSTITUTTET NO (OSLO) participant 644˙373.00
7    BAYLOR COLLEGE OF MEDICINE US (HOUSTON TX) participant 596˙872.00
8    TERVEYDEN JA HYVINVOINNIN LAITOS FI (HELSINKI) participant 586˙925.00
9    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 522˙242.00
10    TECHNISCHE UNIVERSITAET GRAZ AT (GRAZ) participant 470˙233.00
11    SIHTASUTUS TARTU ULIKOOLI KLIINIKUM EE (TARTU) participant 467˙550.00
12    UNIVERSITA DEGLI STUDI DI SIENA IT (SIENA) participant 457˙602.00
13    TARTU ULIKOOL EE (TARTU) participant 417˙811.00
14    PIRKANMAA HOSPITAL DISTRICT FI (TAMPERE) participant 414˙205.00
15    DEN SELVEJENDE INSTITUTION DANSK BORNEASTMA CENTER DK (GENTOFTE) participant 397˙915.00
16    CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT CH (NEUCHATEL) participant 355˙930.00
17    CESKA ZEMEDELSKA UNIVERZITA V PRAZE CZ (PRAHA) participant 298˙436.00
18    OULUN YLIOPISTO FI (OULU) participant 287˙096.00
19    GNOMON Informatics SA EL (Thessaloniki) participant 279˙858.00
20    EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH DE (BONN) participant 249˙572.00
21    SATELLIO OY FI (HELSINKI) participant 219˙351.00
22    LUONNONVARAKESKUS FI (HELSINKI) participant 186˙405.00

Map

 Project objective

Immune-mediated diseases (IMDs) are increasing rapidly in the developed countries constituting a huge medical, economic and societal challenge. The reasons to this epidemic are not known, but exposome needs to play an important role since genetic factors cannot explain such a rapid change. In the HEDIMED project altogether 20 academic and industrial partners will join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving this epidemic. The project is based on a combination of data and biological samples from large clinical cohorts constituting the largest clinical resource in this field including 350.000 pregnant women, 28.000 children prospectively followed from birth and 6.600 children from cross-sectional studies. HEDIMED focuses on common chronic IMDs that cause a significant disease burden, including type 1 diabetes, celiac disease, allergies and asthma. Exposomic disease determinants and the underlying biological pathways will be identified by exploratory approach using advanced omics and multiplex technologies combined with cutting–edge datamining technologies. Particular emphasis is paid on early fetal and childhood exposome since the disease process is known to start early. Inclusion of several IMDs makes it possible to identify determinants that are common for many IMDs facilitating the development of widely operating treatments. HEDIMED includes also data and samples from clinical trials that have used exposomice interventions and cell and organ culture models to help the identification of causal associations. HEDIMED will generate an open-access toolbox that offers various kind of data, new technologies, interactions forums, latest information and functional tools for several stakeholders to facilitate the efforts to find ways to control the IMD epidemic. HEDIMED will generate several innovations which can become exploited widely in diagnostic, therapeutic, preventive and health-economical applications. HEDIMED will work together with the other projects (EXPANSE, HEAP, ATHLETE, EQUAL-LIFE, LONGITOOLS, EPHOR, REMEDIA and EXIMIOUS) funded within the Human Exposome programme call H2020 SC1-BHC-2018-2020, in order to achieve collaboration and synergy

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEDIMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEDIMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.2.)

ECRC (2019)

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

Read More  

EMPOWER (2020)

European platforM to PromOte Wellbeing and HEalth in the woRkplace

Read More  

ONCOBIOME (2019)

Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

Read More